Literature DB >> 15476617

Usefulness of hyperglycemia in predicting renal and myocardial injury in patients with diabetes mellitus undergoing percutaneous coronary intervention.

Bryan J Robertson1, Joseph A Gascho, Robert A Gabbay, Patrick H McNulty.   

Abstract

A retrospective analysis of 165 patients who had diabetes mellitus and underwent percutaneous coronary intervention (PCI) between 1998 and 2003 demonstrated that those whose plasma glucose levels were >/=200 mg/dl before PCI exhibited greater creatine phosphokinase release and serum creatinine increases after PCI. These observations identified hyperglycemia as a potentially modifiable mediator of myocardial and renal injuries in patients who have diabetes and have undergone PCI.

Entities:  

Mesh:

Year:  2004        PMID: 15476617     DOI: 10.1016/j.amjcard.2004.06.059

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  4 in total

1.  Influence of diabetes on >10-year outcomes after percutaneous coronary intervention.

Authors:  Takatoshi Kasai; Katsumi Miyauchi; Kan Kajimoto; Naozumi Kubota; Takeshi Kurata; Hiroyuki Daida
Journal:  Heart Vessels       Date:  2008-05-17       Impact factor: 2.037

2.  Periprocedural glycemic control in patients with diabetes mellitus undergoing coronary angiography with possible percutaneous coronary intervention.

Authors:  Binita Shah; Jeffrey S Berger; Nicholas S Amoroso; Xingchen Mai; Jeffrey D Lorin; Ann Danoff; Arthur Z Schwartzbard; Iryna Lobach; Yu Guo; Frederick Feit; James Slater; Michael J Attubato; Steven P Sedlis
Journal:  Am J Cardiol       Date:  2014-02-12       Impact factor: 2.778

3.  Periprocedural management of the patient with diabetes mellitus undergoing coronary angiography: current practice.

Authors:  Binita Shah; Ann Danoff; Martha J Radford; Linda Rolnitzky; Steven P Sedlis
Journal:  Arch Intern Med       Date:  2012-10-22

4.  Glycemic Control in Coronary Revascularization.

Authors:  Francisco Ujueta; Ephraim N Weiss; Steven P Sedlis; Binita Shah
Journal:  Curr Treat Options Cardiovasc Med       Date:  2016-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.